Recent Updates
Recently added Catalysts
KNSA Positive Sentiment Score: 70/100

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Tuesday, November 12, 2024 1 min read
Key Takeaway: Kiniksa Pharmaceuticals International, plc is set to present at the 2024 Jefferies London Healthcare Conference on November 19, 2024. The management will engage in a fireside chat to discuss the company's therapeutic innovations and pipeline. A live webcast and a replay of the event will be available on Kiniksa's website. The company specializes in developing therapies for patients with serious diseases that currently have limited treatment options.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kiniksa is participating in a prominent healthcare conference.
  • The company is focused on addressing significant unmet medical needs.
  • Kiniksa's immune-modulating assets show potential for differentiation in the market.

Full Press Release Details

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
jkirshenbaum@kiniksa.com
Kiniksa Media Contact

Frequently Asked Questions

When is Kiniksa's fireside chat at the Jefferies Conference?

Kiniksa's fireside chat is on November 19, 2024, at 12:00 p.m. GMT.

How can I access Kiniksa's presentation webcast?

The webcast can be accessed through the Investors section of Kiniksa's website.

Will there be a replay of the Kiniksa event?

Yes, a replay will be available on Kiniksa's website within 48 hours post-event.

What does Kiniksa Pharmaceuticals focus on?

Kiniksa focuses on developing therapies for debilitating diseases with unmet needs.

Who should be contacted for Kiniksa investor inquiries?

Investor inquiries can be directed to Jonathan Kirshenbaum via email.

Tags: KNSA Viatris Investor Conferences Healthcare Kiniksa Pharmaceuticals Healthcare Conference London biopharmaceuticals
Last updated: Nov 12, 2024